Tilray Brands (TLRY) Income from Non-Controlling Interests (2020 - 2026)

Tilray Brands (TLRY) reported Income from Non-Controlling Interests of $1.3 million for Q1 2026, up 132.67% on a YoY basis from $575482.1 in Q1 2025, and down 5.84% quarter-over-quarter from $1.4 million in Q4 2025.

Tilray Brands (TLRY) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Tilray Brands has reported Income from Non-Controlling Interests for 7 years, with the latest figure at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Income from Non-Controlling Interests rose 132.67% year-over-year to $1.3 million; the trailing twelve-month figure through Feb 2026 stood at $10.2 million (down 34.62% YoY), and the FY2025 full-year result was $5.4 million, down 76.19% from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at $1.3 million, down from $1.4 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $20.3 million in Q2 2022, with the low at -$12.3 million in Q1 2024.
  • Historically, Income from Non-Controlling Interests has averaged $4.2 million across 5 years, with a median of $2.8 million in 2023.
  • The largest YoY upside for Income from Non-Controlling Interests was 50146.88% in 2024 against a maximum downside of 704.85% in 2024.
  • Tilray Brands' Income from Non-Controlling Interests stood at $7.3 million in 2022, then plunged by 61.36% to $2.8 million in 2023, then sank by 128.99% to -$819000.0 in 2024, then surged by 273.63% to $1.4 million in 2025, then fell by 5.84% to $1.3 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $1.3 million (Q1 2026), $1.4 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Tilray Brands - - 54.95 Mn 1.34 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 1.34 Mn
Nov 30, 2025 1.42 Mn
Aug 31, 2025 1.84 Mn
May 31, 2025 5.65 Mn
Feb 28, 2025 -4.10 Mn
Nov 30, 2024 -819,000.00
Aug 31, 2024 4.51 Mn
May 31, 2024 16.08 Mn
Feb 29, 2024 -12.28 Mn
Nov 30, 2023 2.83 Mn
Aug 31, 2023 15.82 Mn
May 31, 2023 32,000.00
Feb 28, 2023 -1.53 Mn
Nov 30, 2022 7.31 Mn
Aug 31, 2022 3.84 Mn
May 31, 2022 20.34 Mn
Feb 28, 2022 9.29 Mn
Nov 30, 2021 -1.02 Mn
Aug 31, 2021 7.05 Mn
May 31, 2021 -6.72 Mn